<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1416">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04450017</url>
  </required_header>
  <id_info>
    <org_study_id>COVID-ICU</org_study_id>
    <nct_id>NCT04450017</nct_id>
  </id_info>
  <brief_title>Clinical Features of Severe Patients With COVID-19</brief_title>
  <official_title>Clinical Features of Severe Patients With COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal Research Clinical Center of Federal Medical &amp; Biological Agency, Russia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal Research Clinical Center of Federal Medical &amp; Biological Agency, Russia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit
      (ICU) community must prepare for the challenges associated with this pandemic. Providing an
      efficient care to the patients of the most severely affected category - intensive care unit
      (ICU) patients - has become one of the serious problems appearing in the COVID-19 pandemics.
      A typical patient's clinical portrait in ICU of COVID centers is very similar in different
      countries, however, the key to improve the treatment results for critically ill patients has
      not yet been found. Data on predictors of severe course in COVID-19 is limited. Knowledge of
      predictors of severe course of disease can lead to different selection of therapeutic
      strategy, determine the group of risk of patients for severe course of disease, and improve
      outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical disease (COVID-19) results in critical illness in about 5% of patients. The aim
      of the study is to identify predictors of the severe pneumonia caused by the SARS-CoV-2
      virus, and to describe the clinical features of patients admitted to an ICU of the
      COVID-center of the Federal Research Clinical Center of Federal Medical &amp; Biological Agency
      on the first day and in dynamics till discharge from the ICU or death.

      The demographic and clinical data will be collected. Laboratory data (hemoglobin,
      lymphocytes, neutrophil to lymphocyte ratio, D-dimer level, IL-6, procalcitonin, glucose
      level, high-sensitive troponin Т, vitamin D level, signs of the presence of a secondary
      bacterial infection, immunogram and Instrumental data (CT-scan, Electrocardiography,
      echocardiography, arterial and venous ultrasound investigation) will be analysed.

      This study is singlecentral observational trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 6, 2020</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mechanical ventilation duration</measure>
    <time_frame>30 days</time_frame>
    <description>The amount of mechanical ventilation days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-invasive Mechanical ventilation duration</measure>
    <time_frame>30 days</time_frame>
    <description>The amount of Non-invasive mechanical ventilation days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>60 days</time_frame>
    <description>The dead and survived patients ratio</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Сomplete blood count</measure>
    <time_frame>Change from baseline on day 5 during ICU treatment</time_frame>
    <description>Сomplete blood count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemistry analysis</measure>
    <time_frame>Change from baseline on day 5 during ICU treatment</time_frame>
    <description>Biochemistry analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Сomplete blood count dynamics</measure>
    <time_frame>Change from baseline on day 15 during ICU treatment</time_frame>
    <description>Сomplete blood count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemistry analysis dynamics</measure>
    <time_frame>Change from baseline on day 15 during ICU treatment</time_frame>
    <description>Biochemistry analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Computer tomography</measure>
    <time_frame>Change from baseline on day 5 during ICU treatment</time_frame>
    <description>Computer tomography of lungs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-sensitive troponin Т</measure>
    <time_frame>Change from baseline on day 5 during ICU treatment</time_frame>
    <description>High-sensitive troponin Т</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-sensitive troponin Т dynamics</measure>
    <time_frame>Change from baseline on day 15 during ICU treatment</time_frame>
    <description>High-sensitive troponin Т</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D level</measure>
    <time_frame>Change from baseline on day 5 during ICU treatment</time_frame>
    <description>Vitamin D level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D level dynamics</measure>
    <time_frame>Change from baseline on day 15 during ICU treatment</time_frame>
    <description>Vitamin D level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunogram</measure>
    <time_frame>Change from baseline on day 5 during ICU treatment</time_frame>
    <description>Immunogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunogram dynamics</measure>
    <time_frame>Change from baseline on day 15 during ICU treatment</time_frame>
    <description>Immunogram</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>SARS-CoV2</condition>
  <arm_group>
    <arm_group_label>Clinical Features of Severe Patients With COVID-19</arm_group_label>
    <description>Critical ill patients with COVID-19 admitted to the ICU. The demographic, clinical data, laboratory data, and Instrumental data will be analysed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>The demographic, clinical, laboratory, and instrumental data</intervention_name>
    <description>Measurement of the demographic, clinical data, laboratory data, and instrumental data</description>
    <arm_group_label>Clinical Features of Severe Patients With COVID-19</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with COVID-19 requiring respiratory support
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients with COVID-19 admitted to the ICU with invasive and noninvasive
             ventilation

        Exclusion Criteria:

          -  less than 24 hours in ICU by any reason,

          -  chronic decompensated diseases with extrapulmonary organ dysfunction (tumour
             progression, liver cirrhosis, congestive heart failure),

          -  atonic coma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tatiana V Klypa, Dr.Med.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal Research Clinical Center of Federal Medical &amp; Biological Agency</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tatiana V Klypa, Dr.Med.Sc.</last_name>
    <phone>+79032599146</phone>
    <email>tvklypa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irina A Mandel, PhD</last_name>
    <phone>+79039528337</phone>
    <email>irina.a.mandel@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Federal Research Clinical Center of Federal Medical &amp; Biological Agency</name>
      <address>
        <city>Moscow</city>
        <zip>115682</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tatiana V Klypa, Dr.Med.Sc.</last_name>
      <phone>+79032599146</phone>
      <email>tvklypa@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Irina A Mandel, PhD</last_name>
      <phone>+79039528337</phone>
      <email>irina.a.mandel@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <reference>
    <citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.</citation>
    <PMID>32007143</PMID>
  </reference>
  <reference>
    <citation>Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, Wooster L, Rotter JI, Guo X, Malhotra R. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2020 May 22. doi: 10.1002/jmv.26050. [Epub ahead of print] Review.</citation>
    <PMID>32441789</PMID>
  </reference>
  <reference>
    <citation>Paranjpe I, Russak A, De Freitas JK, Lala A, Miotto R, Vaid A, Johnson KW, Danieletto M, Golden E, Meyer D, Singh M, Somani S, Manna S, Nangia U, Kapoor A, O'Hagan R, O'Reilly PF, Huckins LM, Glowe P, Kia A, Timsina P, Freeman RM, Levin MA, Jhang J, Firpo A, Kovatch P, Finkelstein J, Aberg JA, Bagiella E, Horowitz CR, Murphy B, Fayad ZA, Narula J, Nestler EJ, Fuster V, Cordon-Cardo C, Charney DS, Reich DL, Just AC, Bottinger EP, Charney AW, Glicksberg BS, Nadkarni G. Clinical Characteristics of Hospitalized Covid-19 Patients in New York City. medRxiv. 2020 Apr 23. pii: 2020.04.19.20062117. doi: 10.1101/2020.04.19.20062117.</citation>
    <PMID>32511655</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 23, 2020</study_first_submitted>
  <study_first_submitted_qc>June 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2020</study_first_posted>
  <last_update_submitted>June 25, 2020</last_update_submitted>
  <last_update_submitted_qc>June 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SARS pneumonia</keyword>
  <keyword>COVID-19</keyword>
  <keyword>severe disease</keyword>
  <keyword>risk factors</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

